CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphomaDavid Martin‐García, Sı́lvia Beà, Alba Navarro et al.|Blood|2018Cited by 112
Motive and opportunity: <i>MYC</i> rearrangements in high-grade B-cell lymphoma with <i>MYC</i> and <i>BCL2</i> rearrangements (an LLMPP study)Laura K. Hilton, David W. Scott, German Ott et al.|Blood|2024Cited by 35
Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphomaWei Li, Kai Fu|Cancer Biology and Medicine|2019Cited by 28
Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T‐cell lymphomasXuhan Zhang, Kai Fu|Hematological Oncology|2019Cited by 27
CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECTBrett Collinge, David W. Scott, Laura K. Hilton et al.|Hematological Oncology|2021Cited by 20